Clinical Trial Update: Analysis of the Resistance and Sensitivity Mechanisms to Teclistamab by Focusing on Single Immune Cell Examination [NA]

View source ↗

Summary

Clinical trial analyzing resistance and sensitivity mechanisms to teclistamab by single immune cell examination in multiple myeloma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Teclistamab (teclistamab)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Multiple Myeloma | NA | Status: RECRUITING